Stock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction

Stock Track

05/08

Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.

The sharp drop followed news that Citizens lowered its price target on Crinetics to $95 from $97, while maintaining an Outperform rating on the shares. Analyst actions often influence market sentiment, and this price target adjustment appears to have contributed to the selling pressure.

Additional analyst commentary on Crinetics Pharmaceuticals was also published around the market open, with multiple firms weighing in on the healthcare sector and specifically mentioning CRNX, potentially adding to the negative investor reaction during the trading session.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1146256721"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146256721\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146256721?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-08 21:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146256721","market":"sg","top_or_hot":-1,"title":"Stock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction","media":"Stock Track","content":"<p>Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.</p><p>The sharp drop followed news that Citizens lowered its price target on Crinetics to $95 from $97, while maintaining an Outperform rating on the shares. Analyst actions often influence market sentiment, and this price target adjustment appears to have contributed to the selling pressure.</p><p>Additional analyst commentary on Crinetics Pharmaceuticals was also published around the market open, with multiple firms weighing in on the healthcare sector and specifically mentioning CRNX, potentially adding to the negative investor reaction during the trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-08 21:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.</p><p>The sharp drop followed news that Citizens lowered its price target on Crinetics to $95 from $97, while maintaining an Outperform rating on the shares. Analyst actions often influence market sentiment, and this price target adjustment appears to have contributed to the selling pressure.</p><p>Additional analyst commentary on Crinetics Pharmaceuticals was also published around the market open, with multiple firms weighing in on the healthcare sector and specifically mentioning CRNX, potentially adding to the negative investor reaction during the trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRNX","symbol_name":"Crinetics Pharmaceuticals Inc.","start_time":0,"source_url":"","article_id":"1146256721","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146256721","pubTimestamp":1778248073,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.The sharp drop followed news that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRNX":"Crinetics Pharmaceuticals Inc."},"translate_title":"个股追踪|分析师下调目标价后Crinetics制药盘中暴跌5.73%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRNX":1},"content_text":"Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.The sharp drop followed news that Citizens lowered its price target on Crinetics to $95 from $97, while maintaining an Outperform rating on the shares. Analyst actions often influence market sentiment, and this price target adjustment appears to have contributed to the selling pressure.Additional analyst commentary on Crinetics Pharmaceuticals was also published around the market open, with multiple firms weighing in on the healthcare sector and specifically mentioning CRNX, potentially adding to the negative investor reaction during the trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}